Search company, investor...

Femta Pharmaceuticals


Series B | Alive

Total Raised


Last Raised

$2.2M | 12 yrs ago

About Femta Pharmaceuticals

Femta is developing a new generation of antibody therapeutics for major disease indications.

Headquarters Location

4510 Executive Drive Suite 322

San Diego, California, 92121,

United States


Missing: Femta Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Femta Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Femta Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Femta Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Femta Pharmaceuticals Patents

Femta Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Units of information, Interleukins, Virus families, Clusters of differentiation, Monoclonal antibodies


Application Date


Grant Date



Related Topics

Units of information, Interleukins, Virus families, Clusters of differentiation, Monoclonal antibodies



Femta Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Femta Pharmaceuticals's headquarters?

    Femta Pharmaceuticals's headquarters is located at 4510 Executive Drive, San Diego.

  • What is Femta Pharmaceuticals's latest funding round?

    Femta Pharmaceuticals's latest funding round is Series B.

  • How much did Femta Pharmaceuticals raise?

    Femta Pharmaceuticals raised a total of $3.2M.

  • Who are the investors of Femta Pharmaceuticals?

    Investors of Femta Pharmaceuticals include Latterell Venture Partners and Biotech Investment Group.

  • Who are Femta Pharmaceuticals's competitors?

    Competitors of Femta Pharmaceuticals include CoImmune, Humanigen, Marval Biosciences, Pervasis Therapeutics, Marcadia Biotech and 11 more.

Compare Femta Pharmaceuticals to Competitors

AdAlta Logo

Which is using a platform-technology approach to develop antibody and peptide-based therapeutics against select targets.


Recodgen is developing therapeutics targeting genetic expressions to disease


Evogenix aims to provide advanced technologies to provide powerful new antibody therapeutics for world markets.

Y's Therapeutics

Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. The company also have small molecule compounds in the company's R&D pipeline to diversify the company's portfolio.

Ascent Therapeutics

Ascent Therapeutics is a biopharmaceutical company developing a approach to the treatment of human disease that rapidly generates pharmaceuticals critical to many disease processes.


NeuroKey A/S develops drugs for the critical care segment addressing the need for emergency medication that can increase the survival rate and reduce the risk of lasting neurological damage in critical care patients.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.